EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development

Dr. Oliver Thompson

American Journal Of Big Data · 2025-04-30 · 6 (2) · 1-5

DOI: 10.71465/ajbd851 ↗

At a glance

Journal article in American Journal Of Big Data, published online on 2025-04-30. Written by Dr. Oliver Thompson. The full text is freely available (open access, CC BY 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The pharmaceutical industry is increasingly turning to Big Data analytics to accelerate drug discovery and development processes. By analyzing vast datasets from diverse sources such as clinical trials, genomics, and patient records, pharmaceutical companies can gain insights into drug efficacy, safety, and potential market success. This paper explores the applications of Big Data in drug development, highlighting how it is transforming the way drugs are identified, tested, and developed.

Cite

APA

Thompson, D. O. (2025). Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development. American Journal Of Big Data, 6(2), 1-5. https://doi.org/10.71465/ajbd851

Vancouver

Thompson DO. Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development. American Journal Of Big Data. 2025;6(2):1-5. doi:10.71465/ajbd851

BibTeX
@article{Thompson2025,
  author = {Thompson, Dr. Oliver},
  title = {Big Data Analytics in the Pharmaceutical Industry: Drug Discovery and Development},
  journal = {American Journal Of Big Data},
  year = {2025},
  volume = {6},
  number = {2},
  pages = {1--5},
  doi = {10.71465/ajbd851}
}
Start for free →